BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Neurodegenerative Diseases

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000092314PMID 16909011
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.

  2004cited by this paper
• Altered Amyloid- (cid:1) Metabolism and Deposition in Genomic-based (cid:1) -Secretase Transgenic Mice*

  2004cited by this paper
• The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates.

  2004cited by this paper
• Transgenic BACE expression in mouse neurons accelerates amyloid plaque pathology

  2004cited by this paper
• Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

  2004cited by this paper
• beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice.

  2004cited by this paper
• Dimeric Amyloid β Protein Rapidly Accumulates in Lipid Rafts followed by Apolipoprotein E and Phosphorylated Tau Accumulation in the Tg2576 Mouse Model of Alzheimer's Disease

  2004cited by this paper
• Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse

  2003cited by this paper
• Characterization of amyloid beta peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein.

  2003cited by this paper
• The Human Amyloid-β Precursor Protein770 Mutation V717F Generates Peptides Longer Than Amyloid-β-(40-42) and Flocculent Amyloid Aggregates*

  2003cited by this paper
• Characterization of amyloid β peptides from brain extracts of transgenic mice overexpressing the London mutant of human amyloid precursor protein

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation

  2003cited by this paper
• Quantification and distribution of beta-secretase alternative splice variants in the rat and human brain.

  2003cited by this paper
• Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.

  2003cited by this paper
• Transgenic mouse models of Alzheimer's disease: phenotype and application

  2003cited by this paper
• Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

  2003cited by this paper
• Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity

  2002cited by this paper
• Correlation Between A x40 – , A x-42 – , and A x-43 – Containing Amyloid Plaques and Cognitive Decline

  2002cited by this paper
• Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model

  2002cited by this paper
• Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

  2002cited by this paper
• Expression of human β‐secretase in the mouse brain increases the steady‐state level of β‐amyloid

  2002cited by this paper
• Substrate and Inhibitor Profile of BACE (β-Secretase) and Comparison with Other Mammalian Aspartic Proteases*

  2002cited by this paper
• Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.

  2001cited by this paper
• BACE1 is the major beta-secretase for generation of Abeta peptides by neurons.

  2001cited by this paper
• Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease.

  2001cited by this paper
• Amyloid β secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease

  2001cited by this paper
• Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695*

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

  2001cited by this paper
• BACE1 is the major β-secretase for generation of Aβ peptides by neurons

  2001cited by this paper
• BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.

  2001cited by this paper
• Correlation Between Aβx-40–, Aβx-42–, and Aβx-43–Containing Amyloid Plaques and Cognitive Decline

  2001cited by this paper
• Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function.

  2001cited by this paper
• Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease.

  2001cited by this paper
• Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

  2000cited by this paper
• Single and multiple transgenic mice as models for Alzheimer's disease.

  2000cited by this paper
• Alzheimer disease: mouse models pave the way for therapeutic opportunities.

  2000cited by this paper
• Growth cone and dendrite dynamics in zebrafish embryos: early events in synaptogenesis imaged in vivo

  2000cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Turnover of Amyloid β-Protein in Mouse Brain and Acute Reduction of Its Level by Phorbol Ester

  1998cited by this paper
• Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

  1998cited by this paper
• Caspase‐mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling

  1998influential reference
• Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• A vector for expressing foreign genes in the brains and hearts of transgenic mice.

  1996cited by this paper
• Prion protein (PrP) with amino‐proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Lack of β-Amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations

  1996influential reference
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• Generation of amyloid beta protein from its precursor is sequence specific.

  1995cited by this paper
• A familial Alzheimer's disease locus on chromosome 1

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

  1994cited by this paper
• Localization of NMDA receptor subunit mRNAs in the rat locus coeruleus.

  1994influential reference
• Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

  1994cited by this paper
• Neuron-specific splicing of the Alzheimer amyloid precursor protein gene in a mini-gene system.

  1993influential reference
• A locus for familial early–onset Alzhelmer's disease on the long arm of chromosome 14, proximal to the α1–antichymotrypsin gene

  1992cited by this paper
• Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids

  1992cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Simplified mammalian DNA isolation procedure.

  1991cited by this paper
• Regulation of Thy-1 gene expression in transgenic mice.

  1987cited by this paper
• Manipulating the mouse embryo: A laboratory manual

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• RECENT PROGRESS IN THE PEROXIDASE‐LABELED ANTIBODY METHOD *

  1975cited by this paper
• β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

  year unknowncited by this paper

• Unfolded protein response signaling by transcription factor XBP‐1 regulates ADAM10 and is affected in Alzheimer's disease

  2014cites this paper
• Preclinical non-human models to combat dementia

  2013cites this paper
• New Small Molecule Drug Discovery for Alzheimer's Disease

  2012cites this paper
• PEGylation enhances the therapeutic potential for insulin-like growth factor I in central nervous system disorders.

  2011cites this paper
• Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice.

  2010cites this paper
• Effect of a Dominant-Negative Form of ADAM10 in a Mouse Model of Alzheimer's Disease

  2009cites this paper
• Upregulation of BACE1 and β-Amyloid Protein Mediated by Chronic Cerebral Hypoperfusion Contributes to Cognitive Impairment and Pathogenesis of Alzheimer’s Disease

  2009cites this paper
• Generation of Aβ38 and Aβ42 Is Independently and Differentially Affected by Familial Alzheimer Disease-associated Presenilin Mutations and γ-Secretase Modulation*

  2008cites this paper
• Generation of Abeta38 and Abeta42 is independently and differentially affected by familial Alzheimer disease-associated presenilin mutations and gamma-secretase modulation.

  2008cites this paper
• Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

  2008cites this paper
• BACE1 and Mutated Presenilin-1 Differently Modulate Aβ40 and Aβ42 Levels and Cerebral Amyloidosis in APPDutch Transgenic Mice

  2007cites this paper
• BACE1 and mutated presenilin-1 differently modulate Abeta40 and Abeta42 levels and cerebral amyloidosis in APPDutch transgenic mice.

  2007cites this paper
• -SiteAmyloidPrecursorProteinCleavingEnzyme1Levels BecomeElevatedinNeuronsaroundAmyloidPlaques: ImplicationsforAlzheimer'sDiseasePathogenesis

  2007cites this paper
• Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

  2007cites this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007cites this paper